From Liston Street Pulse:
Amgen Inc. (AMGN) announced on Sunday that it has agreed to acquire Onyx Pharmaceuticals (ONXX) in an all-cash deal estimated at nearly $10.4 billion, a move which would allow the company to gain traction in one of the biggest and fastest growing market, cancer treatments. The deal will give Amgen access to three anticancer treatments. […]
The post Amgen to Acquire Onyx Pharmaceuticals appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015